NEWSLETTER
Bringing you timely information, the NAVIPPRO Signal e-newsletter focuses on the specific needs of pharmaceutical and public health professionals involved in the risk management of opioid analgesics and other schedule II and III therapeutic agents.
In each issue, we'll examine developments that may change the shape of pharmaceutical risk management. We'll also provide updates on the comprehensive NAVIPPROTM solution.
Sign up now and have NAVIPPRO Signal sent directly to your inbox.
(* = current issue)
2009 - NAVIPPRO Signal E-Newsletter
2008 - NAVIPPRO Signal E-Newsletter
2007 - NAVIPPRO Signal E-Newsletter